Management and Executive

Engineering and Development

Product Management

Accounting and Finance

Marketing

Sales

President & CEO

Co-founder and lead for PsychU (www.PsychU.org)

Otsuka and Lundbeck receive Complete Response Letter from U.S. FDA for sNDA of REXULTI® (brexpiprazole) in combination with sertraline for the treatment of adults with PTSD

Rare Kidney Disease Community Members Join American Kidney Fund and IgA Nephropathy Foundation on Capitol Hill to Champion Key Legislation

Bipolar Disorder Market Research Report 2025-2035 | Pharma Leaders Advance Bipolar Disorder Treatment with Targeted Therapies and Genomic Innovation

Schizophrenia Market Research and Forecast Report 2025-2034 | Emerging Therapies and Genetic Research Drive Growth with Bristol Myers Squibb, AstraZeneca, and Eli Lilly Leading

Executive Director, Sales and Marketing, Neurology Rare Disease

Otsuka Pharmaceutical Companies is committed to pioneering advancements in rare conditions with high unmet needs. The Executive Director, Sales and Marketing, Neurology Rare Disease will lead the brand strategy and commercial tactical planning for an upcoming Rare Disease, Neurology launch, while overseeing account teams and ensuring successful implementation of action plans.

Director, Long-Term Care, National Accounts

Account Manager, Neuroscience

Account sales manager neuroscience

Nephrology Account Manager

Sign up with Google

Sign in with Google